Reach Us +44 1202068036


Formulation and evaluation of Deflazacort controlled release tablets

The objective of the study was to develop matrix tablets for oral controlled release of Deflazacort. In present study controlled release tablets of deflazocart were successfully developed using wet granulation method. To achieve better patient compliance and for prolonged release of drug from the dosage form. Formulation development of diffusion based controlled release matrix tablets of Deflazacort using polymers such as HPMC K100M, Ethylcellulose 50CPS and HPC and their combinations and selection of the best formulation among them. Flow properties – Angle of repose, loose bulk density, tapped density and also % Carr’s compressibility was determined for all the formulations which showed good flow property. The thickness found uniform, hardness and friability values of all the formulation tablets prepared by wet granulation method were within the limits and found to be mechanically stable. In vitro dissolution results showed that % of drug release was prolonged in formulation F12 that is up to 12 hours when compared to other formulations. This indicates that the drug released from the formulation F12 was effective up to 12 hours.

Author(s): D. Vijaya Kumar, O. Kumar, A. Premalatha, K. V. R. N. S. Ramesh, M. Raj Kumar

Abstract | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
30+ Million Readerbase
Recommended Conferences
Flyer image
Abstracted/Indexed in
  • Chemical Abstracts Service (CAS)
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • Proquest Summons
  • EBSCO Host
  • International Committee of Medical Journal Editors (ICMJE)
  • Serials Union Catalogue (SUNCAT)
  • Geneva Foundation for Medical Education and Research
  • Secret Search Engine Labs